Literature DB >> 7480822

Postoperative radiotherapy in carcinoma of the cervix: treatment results and prognostic factors.

G Atkovar1, M Ozşahin, S Koca, I Sahinler, S Okkan, R Uzel.   

Abstract

In order to assess the role of postoperative radiotherapy and prognostic factors, 126 patients who were treated with radiotherapy after surgery for clinical early-stage carcinoma of the cervix were reviewed. All patients received external pelvic radiotherapy and 37 patients were treated with additional vaginal cuff irradiation. The 5-year overall survival, disease-free survival and locoregional control rates were 71.1, 69.9 and 78.1%, respectively. The 5-year disease-free survival rates were 40% for grade 3 vs. 75.4% for grade 1 tumours (p = 0.05), 76.5% for pathological stage IB versus 54.1% for pathological stage IIA (p = 0.04), 36.6% for node-positive patients versus 82.5% for node-negative patients (p = 0.0017), 54% for full thickness cervical invasion versus 100% superficial cervical invasion (p = 0.01), 34.8% for positive margins versus 78.1 for negative margins (p < 0.0001). After a multivariate analysis, tumour grade (p = 0.026) and presence of positive margins (p = 0.006) were found to independently influence the outcome. Grade II and III complication rate was 5.5% in all patients. In conclusion, postoperative radiotherapy should be used in patients treated with simple hysterectomy as well as those treated with radical hysterectomy with unfavorable pathological findings.

Entities:  

Mesh:

Year:  1995        PMID: 7480822     DOI: 10.1016/0167-8140(95)01570-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  [Lymphatic vessel invasion in FIGO-stage-Ib cervical carcinoma: the prognostic relevance and role of adjuvant radiotherapy].

Authors:  V Strnad
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

2.  Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Prognostic factors and complications.

Authors:  M Chatani; T Nose; N Masaki; T Inoue
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

3.  Comparison of chemoradiotherapy with and without brachytherapy as adjuvant therapy after radical surgery in early-stage cervical cancer with poor prognostic factors: An observational study.

Authors:  Mei-Ling Lan; Xian Yu; He Xiao; Peng Zhou; Nan Hu; Yun Liu; Ge Wang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

4.  Adjuvant external beam radiation and brachytherapy for vaginal resection margin positive cervical cancer.

Authors:  Donghyun Kim; Yongkan Ki; Wontaek Kim; Dahl Park; Joohye Lee; Jayoung Lee; Hosang Jeon; Jiho Nam
Journal:  Radiat Oncol J       Date:  2018-06-29

5.  Practice patterns of adjuvant therapy for intermediate/high recurrence risk cervical cancer patients in Japan.

Authors:  Yuji Ikeda; Akiko Furusawa; Ryo Kitagawa; Aya Tokinaga; Fuminori Ito; Masayo Ukita; Hidetaka Nomura; Wataru Yamagami; Hiroshi Tanabe; Mikio Mikami; Nobuhiro Takeshima; Nobuo Yaegashi
Journal:  J Gynecol Oncol       Date:  2016-05       Impact factor: 4.401

6.  Pattern of Failure with Locally Advanced Cervical Cancer– A Retrospective Audit and Analysis of Contributory Factors

Authors:  Anis Bandyopadhyay; Upasana Mukherjee; Sandip Ghosh; Saurav Ghosh; Shyamal Kumar Sarkar
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

7.  Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm.

Authors:  Ran Chu; Yue Zhang; Xu Qiao; Lin Xie; Wei Chen; Ying Zhao; Yintao Xu; Zeng Yuan; Xiaolin Liu; Aijun Yin; Zhiwen Wang; Qing Zhang; Xingsheng Yang; Xuantao Su; Beihua Kong; Kun Song
Journal:  Oncologist       Date:  2021-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.